Scientists Launch Trial To Test Long-Acting Antibody For Long Covid
Long Covid affects people after an infection caused by the SARS-CoV-2 virus. The condition not properly defined yet presents with more than 200 symptoms.
The team from the Nova Southeastern University (NSU) and the Schmidt Initiative for Long Covid (SILC) announced that a clinical trial is underway to assess the effectiveness and safety of sipavibart -- a long-acting monoclonal antibody designed by British drugmaker AstraZeneca's to protect the condition.
The team enrolled 100 patients in the multi-year research, reviewed and cleared by the FDA earlier this year. It aims to improve patients Long Covid symptoms and restore them to full health.
'Like many multi-symptom, post-viral conditions, Long Covid is incredibly complicated and thus little understood,' said Nancy Klimas, director of the Institute for Neuro-lmmune Medicine at NSU.
'Finding a treatment will be life-changing for patients suffering from the myriad symptoms of Long Covid,' she added.
The study will test whether the monoclonal antibody sipavibart -- approved for the pre-exposure prophylaxis (prevention) of Covid-19 in Japan and the EU -- is effective in treating Long Covid. The trial is one of three Long Covid treatment trials expected to begin in 2025.
'Long Covid affects at least 65 million people worldwide, and with more than 200 symptoms, the health impacts of the disease can be debilitating,' said Dr. John Redd, CEO of SILC.
'This trial represents our overall commitment to addressing the most pressing health challenges of our time. We're leveraging our research expertise to potentially transform treatment options for millions suffering from Long Covid, advance knowledge, and improve patient outcomes through innovative clinical research,' added Dr. Ken Dawson-Scully, NSU's senior vice president for research and associate provost.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
3 hours ago
- First Post
New variant Stratus causes spike in Covid-19 cases: What are its symptoms?
Symptoms are similar to other Omicron subvariants, including fever, chills, shortness of breath, sore throat, fatigue, headache, nausea, vomiting, muscle aches, loss of taste or smell, and diarrhoea The Chief Minister has also questioned whether the Covid vaccine might have anything to do with these deaths. Pixabay/Representational Image Several western US states are seeing sharp increases in Covid-19 activity, with the latest Centers for Disease Control and Prevention (CDC) data showing wastewater virus levels at their highest since winter. In an update released Friday, the CDC said national wastewater indicators have risen to a 'moderate' level, up from 'low' the previous week. Alaska, California, Colorado, Nevada and Utah are all classified as 'high.' 'Wastewater monitoring can detect viruses spreading from one person to another within a community earlier than clinical testing,' the CDC said, noting that elevated levels often signal increased infection risk. California's own tracking shows viral loads now surpassing last winter's peaks. STORY CONTINUES BELOW THIS AD Other metrics are climbing as well. As of Tuesday (August 12), infections were growing or likely growing in 45 states, up from 40 the previous week. New variant 'Stratus' emerging A new Covid-19 variant, XFG, nicknamed 'Stratus', has to become the third-most common strain in the US this summer. First detected in Southeast Asia in January, it remained rare in the US until May but by late June was estimated to account for up to 14 per cent of cases. Symptoms are similar to other Omicron subvariants, including fever, chills, shortness of breath, sore throat, fatigue, headache, nausea, vomiting, muscle aches, loss of taste or smell, and diarrhoea. Some patients have also reported a distinctive hoarseness or raspy voice, which could help distinguish XFG from other strains. Physician Jon LaPook told CBS in July that summer upticks in Covid-19 are 'typical' as people gather indoors to escape extreme heat. Federal vaccine contracts cut The surge comes as the US Department of Health and Human Services announced Tuesday it would end 22 federal contracts for mRNA-based vaccines, a technology credited with helping bring the pandemic under control. The move has raised questions about the future of Covid-19 vaccine development.
The Hindu
3 hours ago
- The Hindu
ICMR to initiate wastewater surveillance for 10 viruses across 50 cities
The Indian Council of Medical Research (ICMR) will initiate wastewater surveillance for 10 viruses across 50 cities, a major jump from the five cities that are currently monitored. The move is aimed at identifying any increase in virus growth trend at the earliest, said ICMR head Rajiv Bahl. 'The next six months will see the scaling up of surveillance across India which will enable us to pick up any rise in virus load in the community. Currently, the COVID-19 virus and polio virus are under surveillance,'' explained Dr. Bahl. The ICMR is involved in establishing environmental surveillance for viruses, including avian influenza virus (AIV) by monitoring surface water and wastewater, particularly in areas with outbreaks, to establish an early warning system. India also has a robust surveillance system for influenza-like illness (ILI) and severe acute respiratory illness (SARI) through ICMR and the Integrated Disease Surveillance Programme (IDSP). Dr. Bahl added that antimicrobial resistance (AMR) surveillance is already being conducted at several hospitals across the country. 'AMR is the ability of microorganisms — bacteria, viruses, fungi, and parasites to evolve and resist the effects of medications designed to kill or inhibit their growth. This resistance renders treatments ineffective, leading to longer periods of illnesses, higher costs, and increased mortality,'' said Dr. Bahl. The Central government is also working on the 'One Health' programme, which aims to bring different sectors together to solve health, productivity, and conservation challenges. The Health Ministry notes that India, with its diverse wildlife, large livestock populations, high density of human population, and diversity of flora, can create opportunities for harmonious coexistence and work to prevent heightened risks for spread of diseases between species. 'The COVID-19 pandemic, recent outbreak of lumpy skin disease in cattle, and the constant threat of avian influenza show that it is not just about addressing diseases from the human health point of view but there is also a need to address the livestock, wildlife and environmental aspects,'' it said in a statement.
The Hindu
3 hours ago
- The Hindu
Works of artists Perumal Da, Manohar Devadoss on display at Aravind Eye Hospital
In a bid to take out the art works of Perumal Da and Manohar Devadoss to the masses, Aravind Eye Care System, for the seventh year, has exhibited the works of two artists at LAICO hall in Aravind Eye Hospital here. The exhibition, displaying a collection of art works, would be open to the public from August 12 to August 15. A. Perumal aka Perumal Da, hailing from Ammapatti, a village in Madurai district, joined Shantiniketan, West Bengal, at the age of 18, and worked at Kalabhavan alongside legendary artists like Nandalal Bose. Artist Ramanan said, 'Unlike his contemporaries, Perumal Da, decorated the walls of tribal Santhal homes around Shantiniketan with vibrant depictions of birds, animals and village life, making art accessible beyond galleries and museums.' Mr. Ramanan said the artist being observant and humble consciously stayed away from public exhibitions, believing art should directly connect people. One of his significant contributions to the world of art was his participation in designing illustrations for the Constitution of India – the only handcrafted, illustrated Constitution in the world. Perumal Da was one of the artists who designed the illustrations in indigenous methods, using gold-leaf and stone colours. Chitra Thulsiraj, in-charge of Aravind Communications, said that after his time in Shantiniketan, he moved to Madurai, where he spent the last 30 year of his life. 'A patient of G. Natchiar at Aravind Eye Hospital, he donated his entire art collection to the hospital after his passing away in 2004,' she added. As he was displeased with the treatment his arts received, he was equally unwilling to sell them for a profit. For that reason, he also restrained from displaying it in any art galleries, she added. Though was based in the distant eastern part of the country, his art transcends boundaries of geography, religion, and class and it speaks of simplicity and honesty, Ms. Thulsiraj stated. In a similar way, the much celebrated art works of Manohar Devadoss, a trained scientist, were placed in the exhibition. Manohar Devadoss, following his education in Madurai and America, began his journey as a chemist in a British factory. Following his return to India in 1972, two incidents struck his life. One, the road accident, which left his wife Mahema paralysed, and the diagnosis of his eye condition. 'With Retinitis Pigmentosa, a progressive eye condition, led to his complete blindness,' said Ms. Thulsiraj. As he started losing his vision, artistic instincts in him provoked him to create intricate black and white sketches. 'Despite his deterioration of eye sight, he took up the job of drawing seriously and even penned eight books,' she noted. In 2020, he was awarded the Padma Shri and in 2021, the Postal Department honoured him with postcards featuring his 'Madurai sketches.' In the subsequent year, Manohar Devadoss passed away leaving behind a legacy of art, resilience and compassion. Ms. Thulsiraj observed that the paintings in the hall carried the history and stories of compassion, love and gratitude. By just visiting the gallery, which is free and open to all, one could revisit history and lives through the eyes of the artists.
